Clinical Trial

The Effect of Vırtual Realıty Glasses on Heart Faılure Patıents

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 3, 2025 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Anxiety and sleep disorders are among the most common symptoms in heart failure patients. In addition to pharmacological methods for anxiety and sleep disorders, non-pharmacological methods can also be used. Among these, anxiety and sleep disorders can be prevented with virtual reality glasses aimed at distraction. This study will be conducted to evaluate the effect of breathing exercises performed with virtual reality glasses on anxiety, sleep quality, and respiratory parameters. The study will be conducted with a total of 45 patients, 15 virtual reality glasses + breathing exercises, 15 breathing exercises, and 15 controls. Those in the virtual reality glasses + breathing exercises group will perform breathing exercises with virtual reality glasses once a day for 7 days. Those in the breathing exercises group will perform only breathing exercises once a day for 7 days. Anxiety, sleep disorders, and respiratory parameters of the patients will be examined.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-18.
Trial Details
NCT Number NCT06838169
Lead Sponsor Bayburt University
Conditions Heart Failure
Enrollment 45 participants
Start Date 2025-10-01
Primary Completion 2025-10-01 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-03